Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a prospective study investigating the utility of Brain Network Activation (BNA) analysis in patients with epilepsy.
BNA technology is based on a network model to depict functional connectivity. The descriptive network model approach provides insights regarding inter-connectivity of brain networks and can describe the temporal-spatial brain activation patterns applied to various types of data-sets including EEG, MEG and fMRI.
In this study it is proposed that synchronization in brain activity may be disrupted in patients who experience frequent seizures and may correspond to functional impairments (e.g., memory, processing speed). As such, BNA analysis may provide additional data that complement current functional assessments, inform clinical assessment and management of epilepsy, and identify subgroups of patients that might be at risk for poor treatment outcomes.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Epilepsy patients Right Temporal Lobe | Epilepsy patients with seizures originating from the right temporal lobe | ||
| Epilepsy patients Left Temporal Lobe | Epilepsy patients with seizures originating from the left temporal lobe | ||
| Healthy | Healthy controls |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Assess the BNA database for Epilepsy population and healthy controls. | Functional networks of brain activity in Epilepsy (Right and Left lobe) and healthy control individuals measured using analysis of EEG Event Related Potential (ERP) data. Clinical assessments battery will be utilized in order to examine different sets of BNA database for Epilepsy pathology and healthy controls. | Epilepsy subjects will perform the BNA testing at baseline prior to change in medication if applicable and 3-10 days following change in medication when applicable. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Participants will be recruited from the long-term EEG monitoring floor and outpatient EEG laboratory. Controls will be recruited in response to advertisements. All participants will be given the BNA Auditory Go/NoGo task. Patient identity will be coded with a master record kept on a password protected computer in the laboratory. Deidentified data will be sent to ElMindA for scoring of the BNA test. Patient data from electronic medical records will be extracted along with patient MRI data processed.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Travis Stoub, PhD | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| RUSH University medical center | Chicago | Illinois | 60612 | United States |
Not provided
| ID | Term |
|---|---|
| D004827 | Epilepsy |
| D004833 | Epilepsy, Temporal Lobe |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D004828 | Epilepsies, Partial |
Not provided
Not provided
Not provided
Not provided
Not provided
| D000073376 | Epileptic Syndromes |